(NASDAQ: ENTX) Entera Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 102.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,348.1%.
Entera Bio's earnings in 2026 is -$12,377,000.On average, 3 Wall Street analysts forecast ENTX's earnings for 2026 to be -$17,071,341, with the lowest ENTX earnings forecast at -$16,401,877, and the highest ENTX earnings forecast at -$17,573,440.
In 2027, ENTX is forecast to generate -$28,619,602 in earnings, with the lowest earnings forecast at -$27,497,264 and the highest earnings forecast at -$29,461,355.